No abstract available
MeSH terms
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / adverse effects
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Bevacizumab
-
Carcinoma, Renal Cell / blood supply
-
Carcinoma, Renal Cell / drug therapy*
-
Drug Synergism
-
Humans
-
Hypertension / chemically induced
-
Indoles / administration & dosage
-
Indoles / adverse effects
-
Kidney Neoplasms / blood supply
-
Kidney Neoplasms / drug therapy*
-
Neovascularization, Pathologic / drug therapy
-
Neovascularization, Pathologic / metabolism
-
Pyrroles / administration & dosage
-
Pyrroles / adverse effects
-
Sunitinib
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Vascular Endothelial Growth Factor A / metabolism
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Indoles
-
Pyrroles
-
Vascular Endothelial Growth Factor A
-
Bevacizumab
-
Sunitinib